Opthea appoints Kathy Connell to board of directors

Opthea (OPT) announced the appointment of Kathy Connell to the Board of Directors as a Non-Executive Director. Ms. Connell’s appointment was effective immediately after the Annual General Meeting of the Company on November 15, 2024. Connell is currently Senior Client Partner and Head of Healthcare and Life Sciences Australia/New Zealand at Korn Ferry. The Company also notes that Megan Baldwin, PhD, retired from the Board as Executive Director, in accordance with ASX Listing Rules. Dr. Baldwin will continue to advance Opthea’s innovation agenda in her executive role as Founder and CIO of the Company.